Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8:14:1282291.
doi: 10.3389/fmicb.2023.1282291. eCollection 2023.

Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen

Affiliations

Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen

Stephanie Hindle et al. Front Microbiol. .

Abstract

Introduction: The use of antiretroviral therapy (ART) during pregnancy, particularly protease-inhibitor-based regimens (PI), has been linked to adverse outcomes including preterm delivery. As this outcome may be related to systemic inflammation, we sought to characterize inflammatory profiles of pregnant people living with HIV (PLWH) by comparing their levels of inflammatory mediators at two timepoints during pregnancy according to ART regimen, and to HIV-negative controls.

Methods: Second and third trimester samples from 144 pregnant PLWH treated with ART and 24 HIV-uninfected controls were retrieved from the CARMA-PREG cohort. Peripheral plasma levels of 12 inflammatory mediators previously linked to HIV infection and/or poor pregnancy outcomes were quantified by multiplex assay: HMGB1, GM-CSF, IFNα, IFNβ, IFNγ, IL-10, IL-17, IL-1β, IL-6, TNFα, AGP, and CRP. Levels were compared by ART regimen and HIV status.

Results: Adjusted analyses showed that PLWH have higher levels of AGP throughout pregnancy and lower levels of IFNγ and IL-1β during the second trimester. PI-based regimens are associated with significantly higher levels of IFNα and IL-17 during the second trimester and IFNα, CRP, HMGB1, and IFNβ during the third trimester compared to InSTI-based regimens. The PI-subgroup was associated with preterm delivery and higher HIV-1 viral load.

Discussion: Our results suggest that PI-based regimens are associated with a pro-inflammatory and antiviral immunological response and a high viral load, which may be a mechanism through which PI-based regimens increase the risk of preterm delivery. Further investigations into cellular mechanisms and pro-inflammatory cascades leading to preterm delivery are necessary to support this association.

Keywords: HIV; antiretroviral therapy; inflammation; pregnancy; premature birth.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Unadjusted analyses comparing log-transformed inflammatory mediator levels by HIV status during the second (A) and third (B) trimesters of pregnancy, represented by median and interquartile range.
Figure 2
Figure 2
Unadjusted analyses comparing log-transformed inflammatory mediator levels by subgroup of antiretrovirals and to HIV-negative controls during the second (A) and third (B) trimesters of pregnancy, represented by median and interquartile range. (PI: protease inhibitor; InSTI: integrase strand-treansfer inhibitor).
Figure 3
Figure 3
Unadjusted analyses comparing log-transformed inflammatory mediator levels by pregnancy outcome (term and preterm) during the second trimester, represented by median and interquartile range.

References

    1. Akoto C., Norris S. A., Hemelaar J. (2021). Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in south African women. Sci. Rep. 11:10079. doi: 10.1038/s41598-021-89551-3, PMID: - DOI - PMC - PubMed
    1. Albert A. Y. K., Elwood C., Wagner E. C., Pakzad Z., Chaworth-Musters T., Berg K., et al. (2020). Investigation of factors associated with spontaneous preterm birth in pregnant women living with Hiv. AIDS 34, 719–727. doi: 10.1097/QAD.0000000000002464, PMID: - DOI - PubMed
    1. Arshad O., Gadawska I., Sattha B., Côté H. C. F., Hsieh A. Y. Y., for the Canadian Institutes of Health Research Team on Cellular Aging and HIV Comorbidities in Women and Children (CARMA) (2018). Elevated cell-free mitochondrial Dna in filtered plasma is associated with Hiv infection and inflammation. Jaids J. Acquired Immune Deficiency Syndromes 78, 111–118. doi: 10.1097/QAI.0000000000001650 - DOI - PubMed
    1. Bastard J. P., Soulié C., Fellahi S., Haïm-Boukobza S., Simon A., Katlama C., et al. (2012). Circulating Interleukin-6 levels correlate with residual Hiv Viraemia and markers of immune dysfunction in treatment-controlled Hiv-infected patients. Antivir. Ther. 17, 915–919. doi: 10.3851/IMP2093, PMID: - DOI - PubMed
    1. Campillo-Gimenez L., Casulli S., Dudoit Y., Seang S., Carcelain G., Lambert-Niclot S., et al. (2014). Neutrophils in antiretroviral therapy–controlled Hiv demonstrate Hyperactivation associated with a specific Il-17/Il-22 environment. J. Allergy Clin. Immunol. 134:E5. doi: 10.1016/j.jaci.2014.05.040 - DOI - PubMed